Results 121 to 130 of about 8,114 (214)

Physiologically‐Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 1, January 2026.
ABSTRACT Pediatric extrapolation strategies issued by health authorities have streamlined pediatric drug development and reduced the unnecessary burden of conducting pediatric clinical studies. In line with these strategies, physiologically based pharmacokinetic (PBPK) models have been utilized extensively for initial dosing regimen and sampling ...
James W. T. Yates   +26 more
wiley   +1 more source

Mirvetuximab Soravtansine: Mechanism of Action, Clinical and Translational Science

open access: yesClinical and Translational Science, Volume 19, Issue 1, January 2026.
ABSTRACT Mirvetuximab soravtansine (MIRV) is an antibody‐drug conjugate (ADC) composed of the DM4 payload conjugated to a folate receptor α (FRα)‐targeting antibody via the cleavable sulfo‐SPDB linker. MIRV targets and binds to FRα with high affinity and specificity, releasing the DM4 payload intracellularly following MIRV‐FRα complex internalization ...
Rajeev Menon   +7 more
wiley   +1 more source

Serum Autoantibody Lowering by the Anti-FcRn Monoclonal Antibody, Nipocalimab, Correlates With Clinical Improvement in Generalized Myasthenia Gravis Patients [PDF]

open access: bronze, 2022
Sindhu Ramchandren   +12 more
openalex   +1 more source

pH-dependent Binding Engineering Reveals an FcRn Affinity Threshold That Governs IgG Recycling [PDF]

open access: hybrid, 2014
M. Jack Borrok   +6 more
openalex   +1 more source

Structural Design and Immunogenicity of a Novel Self‐Adjuvanting Mucosal Vaccine Candidate for SARS‐CoV‐2 Expressed in Plants

open access: yesPlant Biotechnology Journal, Volume 24, Issue 1, Page 284-299, January 2026.
ABSTRACT Mucosal vaccination for COVID‐19 to boost preexisting though insufficient systemic and local/mucosal immunity remains an attractive prospect but there are currently no licensed mucosal vaccines against this infection. Here, using a plant expression system, we developed a novel mucosal vaccine platform for respiratory viruses and demonstrated ...
Mi‐Young Kim   +13 more
wiley   +1 more source

Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics [PDF]

open access: gold, 2017
Nicole Piche‐Nicholas   +7 more
openalex   +1 more source

Identifying Red Flags in Myasthenia Gravis Diagnosis, Reassessment, and Myasthenic Crisis: An Italian Delphi‐Based Position Paper

open access: yesActa Neurologica Scandinavica, Volume 2026, Issue 1, 2026.
Background and Purpose Myasthenia gravis (MG) is a complex autoimmune disorder affecting neuromuscular transmission, often leading to diagnostic and therapeutic challenges. Timely identification of “red flags” in diagnosis, therapeutic reassessment, and myasthenic crisis is crucial to optimizing patient outcomes. This Delphi‐based consensus is aimed at
Francesco Habetswallner   +19 more
wiley   +1 more source

The neonatal Fc receptor (FcRn) is required for porcine reproductive and respiratory syndrome virus uncoating

open access: yesJournal of Virology
Porcine reproductive and respiratory syndrome virus (PRRSV) continues to cause substantial economic losses to the pig industry worldwide. Previous studies from other groups showed that CD163 is required for PRRSV uncoating and genome release.
Kang Yang   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy